Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Encompass Health Corp shares valued at $1,058,474 were sold by COLTHARP DOUGLAS E on Aug 13 ’24. At $86.34 per share, COLTHARP DOUGLAS E sold 12,260 shares. The insider’s holdings dropped to 136,227 shares worth approximately $13.88 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Douglas Coltharp purchased 12,260 shares, netting a total of over 1,058,520 in proceeds.
Before that, Charbonneau Elissa Joy had sold 10,000 shares from its account. In a trade valued at $850,200, the Chief Medical Officer traded Encompass Health Corp shares for $85.02 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $1.89 million.
As published in their initiating research note from KeyBanc Capital Markets on October 11, 2024, Encompass Health Corp [EHC] has been an Overweight and the price target has been revised to $115. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early July. As of March 06, 2024, Barclays has initiated its “an Overweight” rating for EHC. Earlier on March 14, 2023, Barclays initiated its rating. Their recommendation was “an Equal weight” for EHC stock.
Analyzing EHC Stock Performance
During the last five days, there has been a surge of approximately 0.56%. Over the course of the year, Encompass Health Corp shares have jumped approximately 52.74%. Shares of the company reached a 52-week high of $103.64 on 11/06/24 and a 52-week low of $65.99 on 01/02/24. A 50-day SMA is recorded $95.04, while a 200-day SMA reached $85.38. Nevertheless, trading volume fell to 0.82 million shares from 0.63 million shares the previous day.
Support And Resistance Levels for Encompass Health Corp (EHC)
According to the 24-hour chart, there is a support level at 99.67, which, if violated, would cause prices to drop to 97.42. In the upper region, resistance lies at 103.90. The next price resistance is at 105.88. RSI (Relative Strength Index) is 66.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.41, which suggests the price will increase in the coming days. Percent R is at 14.77%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
